Subcutaneous administration of nano- and microsuspensions of poorly soluble compounds to rats

Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages

(2012) Shann Yu et al.   International Journal of Nanomedicine

Interaction of Mesoporous Silica Nanoparticles with Human Red Blood Cell Membranes: Size and Surface Effects

(2011) Yannan Zhao et al.   ACS Nano

Targeting the lymphatics using dendritic polymers (dendrimers)

(2011) Lisa M. Kaminskas et al.   ADVANCED DRUG DELIVERY REVIEWS

Physical and chemical stability of drug nanoparticles

(2011) Libo Wu et al.   ADVANCED DRUG DELIVERY REVIEWS

Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles

(2011) Shuang Cai et al.   ADVANCED DRUG DELIVERY REVIEWS

Co-administration of a nanosuspension of a poorly soluble basic compound and a solution of a proton pump inhibitor—the importance of gastrointestinal pH and solubility for thein vivoexposure

(2011) Kalle Sigfridsson et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Improvement of low bioavailability of a novel factor Xa inhibitor through formulation of cationic additives in its oral dosage form

(2011) Yoshimine Fujii et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Intratumoral Drug Delivery with Nanoparticulate Carriers

(2011) Hillary Holback et al.   PHARMACEUTICAL RESEARCH

A formulation comparison between micro- and nanosuspensions: the importance of particle size for absorption of a model compound, following repeated oral administration to rats during early development

(2010) Kalle Sigfridsson et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Particle size reduction and pharmacokinetic evaluation of a poorly soluble acid and a poorly soluble base during early development

(2010) Kalle Sigfridsson et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Nanosuspensions: A promising formulation for the new phospholipase A2 inhibitor PX-18

(2010) Jana Pardeike et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Oral drug delivery in personalized medicine: Unmet needs and novel approaches

(2010) Klaus Wening et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Controlled Delivery of Basal Insulin from Phase-Sensitive Polymeric Systems After Subcutaneous Administration: In Vitro Release, Stability, Biocompatibility, In Vivo Absorption, and Bioactivity of Insulin

(2010) Khaled Al-Tahami et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Usefulness of a Nanoparticle Formulation to Investigate Some Hemodynamic Parameters of a Poorly Soluble Compound

(2010) Kalle Sigfridsson et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review)

(2010) Ryan B. Huang et al.   MOLECULAR MEMBRANE BIOLOGY

A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions

(2009) Sudhir Verma et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Production and characterization of Hesperetin nanosuspensions for dermal delivery

(2009) Prabhat R. Mishra et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Improved Lysozyme Stability and Release Properties of Poly(lactide-co-glycolide) Implants Prepared by Hot-Melt Extrusion

(2009) Zahra Ghalanbor et al.   PHARMACEUTICAL RESEARCH

Formulation of Nanosuspensions of Albendazole for Oral Administration

(2008) Yamasani Rao et al.   Current Nanoscience

Absorption kinetics of insulin after subcutaneous administration

(2008) Tue Søeborg et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Inhaled nanoparticles—A current review

(2008) Wei Yang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Injectable Biodegradable Polyurethane Scaffolds with Release of Platelet-derived Growth Factor for Tissue Repair and Regeneration

(2008) Andrea E. Hafeman et al.   PHARMACEUTICAL RESEARCH

Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification

(2007) G. Gasparini et al.   COLLOIDS AND SURFACES B-BIOINTERFACES